PREDICT: Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements

Kernel

Summary

The purpose of the current study is to perform a unified, homogeneous data collection protocol that includes a large cohort of patients undergoing different treatment options for Major Depressive Disorder (MDD) as an avenue for investigating optimal biomarkers for depression treatments on an individual patient level.

Eligibility

Age range: 18–75 years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: Ketamine cohort * Adult between the ages of 18 - 65, inclusive at time of enrollment * Primary diagnosis of MDD as defined by DSM-5 * Determined by clinic to be eligible for ketamine treatment and agrees to receive ketamine treatment * Agrees to start ketamine treatment in conjunction with study participation to capture pre-treatment measurements accurately * Has not received a ketamine treatment course in the past 12 months * Has not received a TMS treatment course in the past 3 months * Ability to consent for themselves * Fluency in English (speaking and reading) SPRAV…

Locations (10)

BrainHealth Solutions
Costa Mesa, California
Kadima Neuropsychiatry Institute
La Jolla, California
Kaizen Brain Center, LLC
La Jolla, California
Bespoke Treatment
Los Angeles, California
UCLA TMS
Los Angeles, California
Bespoke Treatment
Los Angeles, California